Sudhanshu Patwardhan is a medical doctor, nicotine expert and health tech entrepreneur from India, based in the U.K. He works on projects around the world to reduce harm from tobacco, especially among the most disadvantaged tobacco user populations.
Is Science Impacting Policy or Policy Impacting Science? GTNF 2026
Scientists have raised concerns that evidence supporting harm reduction and flexible regulation is being overlooked.
Don’t Be Afraid to Fail: GTNF 2026
Innovation in the nicotine sector is increasingly being shaped by regulation, consumer needs and the ability of companies to test, fail, and iterate.
Up-and-Coming Nicotine Innovators
Emerging nicotine companies said regulatory barriers, consumer education and the infrastructure surrounding products are increasingly shaping innovation.
Innovation Requires Regulatory Viability: GTNF 2026
Innovation in tobacco and nicotine products is advancing rapidly, but companies must account for regulation, product standards and consumer needs alongside science and technology.
Illicit Market Threatens Harm Reduction Progress
The growing illicit nicotine market is creating risks for brand protection, consumer safety and tobacco harm reduction.
GTNF Keynote Challenges Tobacco Control’s Approach
Dessart said climate policy has embraced collaboration with industry, while a restrictive interpretation of FCTC has ignored tobacco-industry stakeholders.
